These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 27882929)

  • 21. GFI1 downregulation promotes inflammation-linked metastasis of colorectal cancer.
    Xing W; Xiao Y; Lu X; Zhu H; He X; Huang W; Lopez ES; Wong J; Ju H; Tian L; Zhang F; Xu H; Wang SD; Li X; Karin M; Ren H
    Cell Death Differ; 2017 May; 24(5):929-943. PubMed ID: 28387757
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An antitumorigenic role for the IL-33 receptor, ST2L, in colon cancer.
    O'Donnell C; Mahmoud A; Keane J; Murphy C; White D; Carey S; O'Riordain M; Bennett MW; Brint E; Houston A
    Br J Cancer; 2016 Jan; 114(1):37-43. PubMed ID: 26679377
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vascular endothelial growth factor-induced skin carcinogenesis depends on recruitment and alternative activation of macrophages.
    Linde N; Lederle W; Depner S; van Rooijen N; Gutschalk CM; Mueller MM
    J Pathol; 2012 May; 227(1):17-28. PubMed ID: 22262122
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interleukin-33 and ST2 Signaling in Tumor Microenvironment.
    Hong J; Kim S; Lin PC
    J Interferon Cytokine Res; 2019 Jan; 39(1):61-71. PubMed ID: 30256696
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Matrix metalloproteases as maestros for the dual role of LPS- and IL-10-stimulated macrophages in cancer cell behaviour.
    Cardoso AP; Pinto ML; Pinto AT; Pinto MT; Monteiro C; Oliveira MI; Santos SG; Relvas JB; Seruca R; Mantovani A; Mareel M; Barbosa MA; Oliveira MJ
    BMC Cancer; 2015 Jun; 15():456. PubMed ID: 26043921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular mechanisms of IL-33-mediated stromal interactions in cancer metastasis.
    Andersson P; Yang Y; Hosaka K; Zhang Y; Fischer C; Braun H; Liu S; Yu G; Liu S; Beyaert R; Chang M; Li Q; Cao Y
    JCI Insight; 2018 Oct; 3(20):. PubMed ID: 30333314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MFHAS1 promotes colorectal cancer progress by regulating polarization of tumor-associated macrophages via STAT6 signaling pathway.
    Chen W; Xu Y; Zhong J; Wang H; Weng M; Cheng Q; Wu Q; Sun Z; Jiang H; Zhu M; Ren Y; Xu P; Chen J; Miao C
    Oncotarget; 2016 Nov; 7(48):78726-78735. PubMed ID: 27783989
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
    Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
    J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interleukin-33 activates and recruits natural killer cells to inhibit pulmonary metastatic cancer development.
    Qi L; Zhang Q; Miao Y; Kang W; Tian Z; Xu D; Xiao W; Fang F
    Int J Cancer; 2020 Mar; 146(5):1421-1434. PubMed ID: 31709531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DHT and Insulin Upregulate Secretion of the Soluble Decoy Receptor of IL-33 From Decidualized Endometrial Stromal Cells.
    Salamon D; Ujvari D; Hellberg A; Hirschberg AL
    Endocrinology; 2023 Nov; 165(1):. PubMed ID: 37972259
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dynamic stromal cellular reaction throughout human colorectal adenoma-carcinoma sequence: A role of TH17/IL-17A.
    Cui G; Li Z; Florholmen J; Goll R
    Biomed Pharmacother; 2021 Aug; 140():111761. PubMed ID: 34044278
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dynamic observation of IL-33 and its receptors in HIV patients who received HAART.
    He B; Zheng L; Zhou H; He Y; Chen Z; Xiao S; Wang H; Ling Y; Zheng Y
    Cell Mol Biol (Noisy-le-grand); 2017 Mar; 63(3):73-77. PubMed ID: 28466817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IL-33-mediated mast cell activation promotes gastric cancer through macrophage mobilization.
    Eissmann MF; Dijkstra C; Jarnicki A; Phesse T; Brunnberg J; Poh AR; Etemadi N; Tsantikos E; Thiem S; Huntington ND; Hibbs ML; Boussioutas A; Grimbaldeston MA; Buchert M; O'Donoghue RJJ; Masson F; Ernst M
    Nat Commun; 2019 Jun; 10(1):2735. PubMed ID: 31227713
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decreased expression of IL-33 in immune thrombocytopenia.
    Li PP; Zhang XM; Yuan D; Liu X; Li Y; Shan NN
    Int Immunopharmacol; 2015 Sep; 28(1):420-4. PubMed ID: 26164496
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IL-33/ST2 axis controls Th2/IL-31 and Th17 immune response in allergic airway diseases.
    Vocca L; Di Sano C; Uasuf CG; Sala A; Riccobono L; Gangemi S; Albano GD; Bonanno A; Gagliardo R; Profita M
    Immunobiology; 2015 Aug; 220(8):954-63. PubMed ID: 25747940
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of LAP
    Zhong W; Jiang ZY; Zhang L; Huang JH; Wang SJ; Liao C; Cai B; Chen LS; Zhang S; Guo Y; Cao YF; Gao F
    World J Gastroenterol; 2017 Jan; 23(3):455-463. PubMed ID: 28210081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IL-33/ST2 as a potential target for tumor immunotherapy.
    Jiang W; Lian J; Yue Y; Zhang Y
    Eur J Immunol; 2021 Aug; 51(8):1943-1955. PubMed ID: 34131922
    [TBL] [Abstract][Full Text] [Related]  

  • 38. S100A4-neutralizing antibody suppresses spontaneous tumor progression, pre-metastatic niche formation and alters T-cell polarization balance.
    Grum-Schwensen B; Klingelhöfer J; Beck M; Bonefeld CM; Hamerlik P; Guldberg P; Grigorian M; Lukanidin E; Ambartsumian N
    BMC Cancer; 2015 Feb; 15():44. PubMed ID: 25884510
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Colorectal cancer cell-derived interleukin-6 enhances the phagocytic capacity and migration of THP-1 cells.
    Yeh KY; Wu TH; Wu TL
    Cytokine; 2016 Mar; 79():82-9. PubMed ID: 26775116
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An Oncolytic Adenovirus Encoding Decorin and Granulocyte Macrophage Colony Stimulating Factor Inhibits Tumor Growth in a Colorectal Tumor Model by Targeting Pro-Tumorigenic Signals and via Immune Activation.
    Liu Z; Yang Y; Zhang X; Wang H; Xu W; Wang H; Xiao F; Bai Z; Yao H; Ma X; Jin L; Wu C; Seth P; Zhang Z; Wang L
    Hum Gene Ther; 2017 Aug; 28(8):667-680. PubMed ID: 28530155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.